MedTrace Logo

Circulating Tumor Material in Colorectal Cancer and Melanoma

NCT02907086 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 7

Last updated 2022-06-06

No results posted yet for this study

Summary

Observational study to allow the collection of blood and medical information to evaluate the role of circulating tumor material in patients with colorectal cancer and melanoma

Conditions

  • Colorectal Cancer and Melanoma

Interventions

OTHER

blood collection

Patients will receive a research draw for circulating tumor material analysis with standard clinical labs

Sponsors & Collaborators

  • Abramson Cancer Center at Penn Medicine

    lead OTHER

Principal Investigators

  • Mark O'Hara, MD · Abramson Cancer Center at Penn Medicine

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-07-07
Primary Completion
2019-07-01
Completion
2020-07-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02907086 on ClinicalTrials.gov